ChildStats.gov—Forum on Child and Family Statistics
faces of children
Home  |  About the Forum  |  Publications  |  Data Sources  |  Help
Search

America's Children: Key National Indicators of Well-Being, 2013

Immunization

Data on vaccination coverage are used to identify groups at risk of vaccine-preventable diseases and to evaluate the effectiveness of programs designed to increase coverage. Rates of childhood and adolescent immunizations are one measure of how extensively children are protected from serious vaccine-preventable illnesses.

Indicator HC3.A: Percentage of children ages 19–35 months with the 4:3:1:3:3:1 combined series of vaccinations by poverty status, 2002–2011
Percentage of children ages 19–35 months with the 4:3:1:3:3:1 combined series of vaccinations by poverty status, 2002–2011

NOTE: The 4:3:1:3:3:1 series consists of 4 doses (or more) of diphtheria, tetanus toxoids, and pertussis (DTP) vaccines, diphtheria and tetanus toxoids (DT), or diphtheria, tetanus toxoids, and any acellular pertussis (DTaP) vaccines; 3 doses (or more) of poliovirus vaccines; 1 dose (or more) of any measles-containing vaccine; 3 doses (or more) of Haemophilus influenzae type b (Hib) vaccines; 3 doses (or more) of hepatitis B vaccines; and 1 dose (or more) of varicella vaccine. The recommended immunization schedule for children is available at http://www.cdc.gov/vaccines/schedules/index.html. In 2009, a Hib vaccine shortage affected the series estimate. The Advisory Committee on Immunization Practices (ACIP) recommended an interim suspension of the booster dose for healthy children. This was during the time when most children in the 2009 National Immunization Survey would have been eligible for the Hib vaccine booster dose.

SOURCE: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases and National Center for Health Statistics, National Immunization Survey.

Indicator HC3.B: Percentage of adolescents ages 13–17 with the routinely recommended-for-age vaccinations, 2006–2011
Percentage of adolescents ages 13–17 with the routinely recommended-for-age vaccinations, 2006–2011

NOTE: Data collection for 2006 and 2007 was only performed during the fourth quarter. Human papillomavirus (HPV) coverage level indicates females initiating the 3-dose series. Routinely recommended vaccines for administration beginning at ages 11–12 include tetanus-diphtheria-acellular pertussis (Tdap) and meningococcal conjugate (MenACWY) vaccines (both one dose), and HPV vaccine (3 doses). Since the routine recommendation for the administration of HPV vaccine to males was not published until December 2011, those vaccination rates are not reported in this figure.

SOURCE: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases and National Center for Health Statistics, National Immunization Survey—Teen.

 

  • In 2011, about 78 percent of children ages 19–35 months had received the recommended combined six-vaccine series.
  • Children living in families with incomes below the poverty level had lower rates of coverage (75 percent), compared with children in families with incomes at or above the poverty level (79 percent).
  • Since 2006, vaccination coverage with routinely recommended vaccines among U.S. adolescents ages 13–17 has increased, but coverage with vaccines recommended at 11 or 12 years of age remains low, especially for human papillomavirus (HPV) vaccine.
  • In 2011, vaccination coverage among U.S. adolescents ages 13–17 for 1 dose (or more) of tetanus, diphtheria, acellular pertussis (Tdap) vaccine was 78 percent; 1 dose (or more) of meningococcal conjugate (MenACWY) vaccine was 71 percent; and 1 dose (or more) of HPV vaccine among females was 53 percent.

 

table icon HC3.A HTML TableHC3.B HTML Table